Meanwhile, our pathway enrichment analysis revealed that genes co-expressed with SLFN5 were correlated with "Immune response IFN-alpha/beta signaling via JAK/STAT" in COAD patients. This evidence concerns the gene SLFN5 and colon adenocarcinoma.